Sign Up Today and Learn More About Allyx Therapeutics Stock
Invest in or calculate the value of your shares in Allyx Therapeutics or other pre-IPO companies through EquityZen's platform.
Allyx Therapeutics Stock
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.
About Allyx Therapeutics Stock
Founded
2018
Headquarters
New Haven, CT, US
Industries
Apps, Artificial Intelligence, Software
Allyx Therapeutics Press Mentions
Stay in the know about the latest news on Allyx Therapeutics
After raising $62M, New Haven biotech Allyx Therapeutics advances experimental Alzheimer’s drug
hartfordbusiness • Jun 17, 2026
Mglur5 modulating compounds, compositions, and methods of use
patents • Feb 12, 2025
Allyx Therapeutics Announces First Alzheimer's Disease
globenewswire • Jun 25, 2024
Allyx Therapeutics Announces Expansion into Parkinson's
globenewswire • Jun 25, 2024
Parkinson's clinical trial of ALX-001 DMT to start by month's end
parkinsonsnewstoday • May 20, 2024
Allyx Therapeutics Management
Leadership team at Allyx Therapeutics
Co-Founder and CEO
Stephen Bloch
Co-Founder
Stephen M. Strittmatter
Join now and verify your accreditation status to gain access to:
- Allyx Therapeutics Current Valuation
- Allyx Therapeutics Stock Price
- Allyx Therapeutics Management
- Available deals in Allyx Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Allyx Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Allyx Therapeutics Revenue and Financials
- Allyx Therapeutics Highlights
- Allyx Therapeutics Business Model
- Allyx Therapeutics Risk Factors
- Allyx Therapeutics Research Report from SACRA Research
Trading Allyx Therapeutics Stock
How to invest in Allyx Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Allyx Therapeutics through EquityZen funds. These investments are made available by existing Allyx Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Allyx Therapeutics stock?
Shareholders can sell their Allyx Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."